Retractable Technologies, Inc. (NYSE:RVP - Get Free Report) CEO Thomas J. Shaw acquired 15,096 shares of Retractable Technologies stock in a transaction that occurred on Tuesday, September 3rd. The stock was bought at an average cost of $0.92 per share, with a total value of $13,888.32. Following the acquisition, the chief executive officer now directly owns 14,629,317 shares of the company's stock, valued at $13,458,971.64. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website.
Retractable Technologies Stock Performance
RVP opened at $0.93 on Thursday. The business has a 50 day moving average price of $1.07 and a two-hundred day moving average price of $1.11. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. The company has a market capitalization of $27.69 million, a price-to-earnings ratio of -3.56 and a beta of 2.08. Retractable Technologies, Inc. has a 1-year low of $0.87 and a 1-year high of $1.34.
Retractable Technologies (NYSE:RVP - Get Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The firm had revenue of $6.03 million during the quarter.
Wall Street Analysts Forecast Growth
War on Elon Escalates…
From Porter & Company | Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.
Separately, StockNews.com started coverage on shares of Retractable Technologies in a research report on Saturday, August 31st. They set a "hold" rating on the stock.
View Our Latest Stock Report on Retractable Technologies
Retractable Technologies Company Profile
(
Get Free Report)
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
